Keywords: s-p, remicade, cleared, eu, early, ra, schering-plough

S-P's Remicade cleared in EU for early RA

Article | 28 June 2004

• Print This

Schering-Plough says that the European Commission has granted approval for Remicade (infliximab), an anti-tumor necrosis factor monoclonal antibody, as a ...

Enjoying this article? To continue reading you need to login or subscribe.